Related Experiment Videos
Ventilatory stimulation by dopamine-receptor antagonists in the mouse
British Journal of Pharmacology
|May 1, 1985
Summary
Neuroleptic drugs impact breathing control in mice by affecting dopamine receptors. These drugs augment ventilation during hypoxia, with effects linked to dopamine and alpha-adrenoceptor affinities, suggesting carotid body involvement.
Area of Science:
- Neuroscience
- Respiratory Physiology
- Pharmacology
Background:
- Dopaminergic mechanisms are implicated in the control of breathing.
- Neuroleptic drugs, known for dopamine receptor antagonism, can influence physiological functions.
Purpose of the Study:
- To investigate the role of dopaminergic mechanisms in modulating ventilatory control in awake mice.
- To determine the relationship between neuroleptic drug properties and their effects on breathing.
Main Methods:
- Ventilation was measured using plethysmography in awake mice.
- Mice received intraperitoneal injections of neuroleptic drugs (haloperidol, droperidol, prochlorperazine, chlorpromazine).
- Effects on ventilation were assessed at rest, during hypoxia, and hypercapnia; carotid body resection was performed in some animals.
Main Results:
- Neuroleptic drugs dose-dependently augmented resting and hypoxic ventilation, while reducing hypercapnic ventilation.
- The augmentation of hypoxic ventilation correlated linearly with the drugs' in vitro affinity for dopamine receptors.
- Differences in drug efficacy were linked to their affinities for alpha-adrenoceptors; combined blockade with phentolamine enhanced effects.
Conclusions:
- Dopaminergic mechanisms within the carotid body play a significant role in modulating ventilatory control in awake mice.
- Neuroleptic drugs that block both dopamine and alpha-adrenoceptors are most effective in augmenting hypoxic ventilation.